James Mond
2017
In 2017, James Mond earned a total compensation of $1.2M as Executive Vice President, Chief Scientific Officer and Chief Medical Officer at ADMA Biologics, a 129% increase compared to previous year.
Compensation breakdown
| Bonus | $127,712 |
|---|---|
| Option Awards | $595,838 |
| Salary | $360,500 |
| Other | $86,161 |
| Total | $1,170,211 |
Mond received $595.8K in option awards, accounting for 51% of the total pay in 2017.
Mond also received $127.7K in bonus, $360.5K in salary and $86.2K in other compensation.
Rankings
In 2017, James Mond's compensation ranked 8,220th out of 14,666 executives tracked by ExecPay. In other words, Mond earned more than 44.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,220 out of 14,666 | 44th |
Division Manufacturing | 3,107 out of 5,772 | 46th |
Major group Chemicals And Allied Products | 1,022 out of 2,075 | 51st |
Industry group Drugs | 804 out of 1,731 | 54th |
Industry Biological Products, Except Diagnostic Substances | 147 out of 313 | 53rd |
Source: SEC filing on April 27, 2018.
Mond's colleagues
We found two more compensation records of executives who worked with James Mond at ADMA Biologics in 2017.
News
ADMA Biologics CEO Adam Grossman's 2021 pay jumps 122% to $4.4M
April 28, 2022
ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M
April 7, 2021
ADMA Biologics CEO Adam Grossman's 2019 pay rises 10% to $1.7M
April 29, 2020
ADMA Biologics CEO Adam Grossman's 2018 pay falls 42% to $1.6M
April 24, 2019